{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:04:41Z","timestamp":1777471481186,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties.<\/jats:p>","DOI":"10.3389\/fnins.2021.732213","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T04:27:30Z","timestamp":1631248050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines"],"prefix":"10.3389","volume":"15","author":[{"given":"Julia E.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn H.","family":"Bagri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen T.","family":"Pagarigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah M.","family":"Belski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecelia","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Bounader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden N.","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary S.","family":"McCarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yebeh.2016.12.024","article-title":"The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication.","volume":"68","author":"Althaus","year":"2017","journal-title":"Epilepsy Behav."},{"key":"B2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/WNP.0000000000000223","article-title":"Is Favorable Outcome Possible After Prolonged Refractory Status Epilepticus?","volume":"33","author":"Alvarez","year":"2016","journal-title":"J. Clin. Neurophysiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuroscience.2019.11.020","article-title":"Screening for efficacious anticonvulsants and neuroprotectants in delayed treatment models of organophosphate-induced status epilepticus.","volume":"425","author":"Barker","year":"2020","journal-title":"Neuroscience"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/epi.12838","article-title":"sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.","volume":"55","author":"Bar-Klein","year":"2014","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jat.2550130306","article-title":"Soman-induced morphological changes: an overview in the non-human primate.","volume":"13","author":"Baze","year":"1993","journal-title":"J. Appl. Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus.","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocritical Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/24734306.2017.1373503","article-title":"Toxic chemical weapons of assassination and warfare: nerve agents VX and sarin.","volume":"1","author":"Chai","year":"2017","journal-title":"Toxicol. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/24734306.2018.1475151","article-title":"Novichok agents: a historical, current, and toxicological perspective.","volume":"2","author":"Chai","year":"2018","journal-title":"Toxicol. Commun."},{"key":"B9","year":"2021","journal-title":"Nerve Agents - Prehospital Management."},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.expneurol.2007.01.001","article-title":"Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.","volume":"204","author":"Deshpande","year":"2007","journal-title":"Exp. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","article-title":"Timing in the treatment of status epilepticus: from basics to the clinic.","volume":"68","author":"Gainza-Lein","year":"","journal-title":"Seizure"},{"key":"B13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.","volume":"75","author":"Gainza-Lein","year":"","journal-title":"JAMA Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: treatment of Convulsive Status Epilepticus in Children and Adults: report of the Guideline Committee of the American Epilepsy Society.","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"B15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/REVEH.1996.11.3.101","article-title":"Thermoregulatory aspects of environmental exposure to anticholinesterase agents.","volume":"11","author":"Gordon","year":"1996","journal-title":"Rev. Environ. Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"104431","DOI":"10.1016\/j.nbd.2019.03.019","article-title":"Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication.","volume":"133","author":"Guignet","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/epi.14630","article-title":"Comparative efficacy of valnoctamide and sec-butylpropylacetamide (SPD) in terminating nerve agent-induced seizures in pediatric rats.","volume":"60","author":"Haines","year":"2019","journal-title":"Epilepsia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1139\/y79-030","article-title":"Metabolic responses to status epilepticus in the rat, cat, and mouse.","volume":"57","author":"Howse","year":"1979","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1164\/rccm.201406-1150CI","article-title":"Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care.","volume":"190","author":"Hulse","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vascn.2019.02.006","article-title":"Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.","volume":"97","author":"Jackson","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0196-0644(05)80120-9","article-title":"Refractory status epilepticus in adults.","volume":"22","author":"Jagoda","year":"1993","journal-title":"Ann. Emerg. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fphar.2019.00560","article-title":"Enaminone modulators of extrasynaptic alpha4beta3delta gamma-aminobutyric acidA receptors reverse electrographic status epilepticus in the rat after acute organophosphorus poisoning.","volume":"10","author":"Johnstone","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.","volume":"381","author":"Kapur","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/epi.14582","article-title":"Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam.","volume":"59","author":"Marrero-Rosado","year":"2018","journal-title":"Epilepsia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.01.010","article-title":"Dexmedetomidine stops benzodiazepine-refractory nerve agent-induced status epilepticus.","volume":"141","author":"McCarren","year":"2018","journal-title":"Epilepsy Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.eplepsyres.2020.106320","article-title":"Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice.","volume":"162","author":"McCarren","year":"2020","journal-title":"Epilepsy Res."},{"key":"B28","first-page":"381","article-title":"Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman.","volume":"19","author":"McDonough","year":"1998","journal-title":"Neurotoxicology"},{"key":"B29","first-page":"123","article-title":"Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment.","volume":"16","author":"McDonough","year":"1995","journal-title":"Neurotoxicology"},{"key":"B30","first-page":"179","article-title":"Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition.","volume":"8","author":"McDonough","year":"1986","journal-title":"Neurobehav. Toxicol. and Teratol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs.","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13181-010-0012-y","article-title":"Hypothermia and Fever after organophosphorus poisoning in humans\u2013a prospective case series.","volume":"6","author":"Moffatt","year":"2010","journal-title":"J. Med. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archneurol.2010.169","article-title":"Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review.","volume":"67","author":"Neligan","year":"2010","journal-title":"Arch. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"104537","DOI":"10.1016\/j.nbd.2019.104537","article-title":"Rational polytherapy in the treatment of cholinergic seizures.","volume":"133","author":"Niquet","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B35","first-page":"61","article-title":"Delayed effects of Soman: brain glucose use and pathology.","volume":"6","author":"Pazdernik","year":"1985","journal-title":"Neurotoxicology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0091-3057(87)90341-8","article-title":"Long-term behavioral changes in rats following organophosphonate exposure.","volume":"27","author":"Raffaele","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/epi4.12389","article-title":"Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury.","volume":"5","author":"Reddy","year":"2020","journal-title":"Epilepsia Open"},{"key":"B38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam.","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/epi.12290","article-title":"Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.","volume":"54","author":"Shekh-Ahmad","year":"2013","journal-title":"Epilepsia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.yebeh.2015.04.012","article-title":"The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.","volume":"49","author":"Shekh-Ahmad","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B41","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity.","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"B42","doi-asserted-by":"crossref","first-page":"II22","DOI":"10.1136\/jnnp.70.suppl_2.ii22","article-title":"The management of status epilepticus.","volume":"70","author":"Shorvon","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol.","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus.","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/jpet.120.000175","article-title":"Delayed adjunctive treatment of organophosphate-induced status epilepticus in rats with phenobarbital, memantine, or dexmedetomidine.","volume":"375","author":"Spampanato","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.359.6382.1314","article-title":"attack puts nerve agent in the spotlight.","volume":"359","author":"Stone","year":"2018","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/2008-2231-20-52","article-title":"Temperature changes among organophosphate poisoned patients. Tehran- Iran.","volume":"20","author":"Talaie","year":"2012","journal-title":"Daru"},{"key":"B48","first-page":"32","article-title":"The role of benzodiazepines in the management of status epilepticus.","volume":"40","author":"Treiman","year":"1990","journal-title":"Neurology"},{"key":"B49","year":"2005","journal-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers."},{"key":"B50","doi-asserted-by":"publisher","first-page":"676358","DOI":"10.1155\/2014\/676358","article-title":"New onset refractory status epilepticus as an unusual presentation of a suspected organophosphate poisoning.","volume":"2014","author":"Waheed","year":"2014","journal-title":"Case Rep. Emerg. Med."},{"key":"B51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4886(88)90010-6","article-title":"Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam.","volume":"101","author":"Walton","year":"1988","journal-title":"Exp. Neurol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2011.03338.x","article-title":"A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.","volume":"53","author":"White","year":"2012","journal-title":"Epilepsia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s002040050187","article-title":"Acute toxicity of cyclohexylmethylphosphonofluoridate (CMPF) in rhesus monkeys: serum biochemical and hematologic changes.","volume":"69","author":"Young","year":"1995","journal-title":"Arch. Toxicol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.732213\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T04:27:48Z","timestamp":1631248068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.732213\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":53,"alternative-id":["10.3389\/fnins.2021.732213"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.732213","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"article-number":"732213"}}